Clinical trial shows oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even alcohol cravings.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup